المؤلفون: Tuttle, RM, Haddad, RI, Ball, DW, Byrd, D, Dickson, P, Duh, QY, Ehya, H, Haymart, M, Hoh, C, Hunt, JP, Iagaru, A, Kandeel, F, Kopp, P, Lamonica, DM, Lydiatt, WM, McCaffrey, J, Moley, JF, Parks, L, Raeburn, CD, Ridge, JA, Ringel, MD, Scheri, RP, Shah, JP, Sherman, SI, Sturgeon, C, Waguespack, SG, Wang, TN, Wirth, LJ, Hoffmann, KG, Hughes, M

المصدر: JNCCN Journal of the National Comprehensive Cancer Network. 12(12)

مصطلحات موضوعية: Rare Diseases, Cancer, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, Oncology & Carcinogenesis

URL الوصول: https://escholarship.org/uc/item/98h712mx

المؤلفون: Sherman, Si, Wirth, Lj, Droz, Jp, Hofmann, M, Bastholt, L, Martins, Rg, Licitra, L, Eschenberg, Mj, Sun, Yn, Juan, T, Stepan, De, Schlumberger, Mj, Motesanib Thyroid Cancer Study Group including Lind, P, Pirich, C, Daumerie, C, Baudin, E, Bui, Bn, Conte Devolx, B, Rohmer, V, Schvartz, C, Szabolcs, I, Racz, K, Brandi, Ml, Pinchera, A, Elisei, R, Orlandi, Fabio, Pacini, F, Jarzab, B, Sowinski, J, Jansson, S, Lundell, G, Hallqvist, A, Meier, C, Philippe, J, Agarwala, S, Ali, H, Barrera, J, Boccia, R, Bukowski, R, Burman, K, Clark, O, Davis, T, Hoff, A, Sarlis, N, Jakub, J, Mena, R, Nahleh, Z, Rosen, L, Stephenson, J, Srkalovic, G, Tchekmedyian, N.

المصدر: New England Journal of Medicine, Vol. 359, No 1 (2008) pp. 31-42
Sherman, S I, Wirth, L J, Droz, J-P, Hofmann, M, Bastholt, L, Martins, R G, Licitra, L, Eschenberg, M J, Sun, Y-N, Juan, T, Stepan, D E, Schlumberger, M J & Study Group, M T C 2008, ' Motesanib diphosphate in progressive differentiated thyroid cancer ', The New England Journal of Medicine, vol. 359, no. 1, pp. 31-42 . https://doi.org/10.1056/NEJMoa075853

مصطلحات موضوعية: Adenoma, Oxyphilic/drug therapy/secondary, Male, Indoles, Thyroid Neoplasms/drug therapy/genetics/pathology, medicine.medical_treatment, Oligonucleotides, Gastroenterology, Motesanib Diphosphate, chemistry.chemical_compound, Adenocarcinoma, Follicular, Motesanib, thyroid cancer, Adenoma, Oxyphilic, Thyroid cancer, ddc:616, Aged, 80 and over, Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors, General Medicine, Middle Aged, Proto-Oncogene Proteins c-kit, Niacinamide, Disease Progression, Adenocarcinoma, Female, Mitogen-Activated Protein Kinases, Adult, medicine.medical_specialty, Adenocarcinoma, Follicular/drug therapy/secondary, Genotype, Antineoplastic Agents, Antineoplastic Agents/adverse effects/therapeutic use, Thyroglobulin, Niacinamide/adverse effects/analogs & derivatives/therapeutic use, Thyroid carcinoma, Text mining, Internal medicine, medicine, Biomarkers, Tumor, Humans, Thyroid Neoplasms, Survival analysis, Aged, Thyroglobulin/blood, business.industry, Disease progression, Cancer, medicine.disease, Survival Analysis, Carcinoma, Papillary, Carcinoma, Papillary/drug therapy/secondary, Receptors, Vascular Endothelial Growth Factor, Endocrinology, chemistry, Indoles/adverse effects/therapeutic use, Cancer research, business, Progressive disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca7ec62fd0d77b607c5390bd8fd6f8ec
https://archive-ouverte.unige.ch/unige:2416

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Schlumberger MJ, Elisei R, Bastholt L, Wirth LJ, Martins RG, Locati LD, Jarzab B, Pacini F, Daumerie C, Droz JP, Eschenberg MJ, Sun YN, Juan T, Stepan DE, Sherman SI

المصدر: Journal of Clinical Oncology; 8/10/2009, Vol. 27 Issue 23, p3794-3801, 8p